AbbVie Inc has agreed to pay US$24 million to settle a lawsuit that alleged insurance fraud by the drugmaker in promoting its blockbuster drug Humira, California's insurance regulator said on Thursday.
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock ExchangeREUTERS: AbbVie Inc has agreed to pay US$24 million to settle a lawsuit that alleged insurance fraud by the drugmaker in promoting its blockbuster drug Humira, California's insurance regulator said on Thursday.
AbbVie denied the allegations, but agreed to look into how Humira is marketed to health care providers in the state, the regulator saidThe Insurance Commissioner of California said the company also agreed to disclose that AbbVie, and not a medical provider, paid the registered nurses who are employed as so-called AbbVie Ambassadors to interact with patients about Humira.
Insurance Commissioner Ricardo Lara said AbbVie has paid US$24 million to California and the whistleblower, a registered nurse who brought the case to the department's attention in October 2016.Humira, the company's flagship arthritis treatment, brought in sales of US$3.97 billion in the latest quarter. It has been the major driver of AbbVie's growth in the recent years but faces expirations of its patents in U.S. in 2023.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »